Oscar Health, Inc. (NYSE:OSCR) Given Consensus Rating of “Hold” by Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have received a consensus recommendation of “Hold” from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $21.56.

A number of equities analysts have issued reports on the stock. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Jefferies Financial Group began coverage on Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company. Finally, Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and cut their target price for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th.

Insider Buying and Selling at Oscar Health

In related news, insider Mario Schlosser sold 6,516 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the sale, the insider now directly owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. The trade was a 7.36 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Steven Wolin sold 19,580 shares of the stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $354,006.40. Following the transaction, the chief operating officer now owns 102,598 shares of the company’s stock, valued at approximately $1,854,971.84. This trade represents a 16.03 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders acquired 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Point72 Hong Kong Ltd bought a new stake in Oscar Health in the 2nd quarter valued at approximately $78,000. Quest Partners LLC acquired a new stake in shares of Oscar Health in the second quarter valued at approximately $93,000. KBC Group NV lifted its position in shares of Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after purchasing an additional 1,328 shares in the last quarter. ORG Wealth Partners LLC acquired a new position in Oscar Health during the fourth quarter worth $100,000. Finally, Amalgamated Bank increased its stake in Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after buying an additional 1,458 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Price Performance

Oscar Health stock opened at $14.94 on Friday. The business’s 50-day simple moving average is $14.95 and its 200 day simple moving average is $16.84. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market cap of $3.69 billion, a price-to-earnings ratio of -248.88, a P/E/G ratio of 0.57 and a beta of 1.70. Oscar Health has a 12-month low of $10.45 and a 12-month high of $23.79.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. During the same period last year, the business posted ($0.29) EPS. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. As a group, research analysts anticipate that Oscar Health will post -0.01 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.